Retraction for Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
- PMID: 41542769
- PMCID: PMC12807460
- DOI: 10.1172/JCI202473
Retraction for Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
Retraction of
-
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.J Clin Invest. 2021 May 17;131(10):e146832. doi: 10.1172/JCI146832. J Clin Invest. 2021. Retraction in: J Clin Invest. 2026 Jan 16;136(2):e202473. doi: 10.1172/JCI202473. PMID: 33830945 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
